Previous 10 | Next 10 |
2023-07-14 03:55:03 ET Summary My passive income for June 2023 was the highest ever, with dividends up by 51.97% year-on-year, covering his mortgage and car payments. The significant dividend growth is attributed to the rapid rise in interest rates over the past 12-18 months, with...
2023-07-13 05:37:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-07-13 03:18:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-07-13 02:30:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
2023-07-12 05:45:00 ET Summary The Akre Focus Fund's Q2 2023 performance was 8.62%, slightly below the S&P 500 Total Return at 8.74%. The fund does not own any of the seven leading AI companies driving index performance, preferring to invest in well-understood businesses. ...
2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...
2023-07-02 22:59:24 ET Summary Thermo Fisher Scientific is a leading healthcare supplier with strong customer relationships and a track record of impressive revenue and net income growth. TMO's superior business model, focused on innovation and serving scientific customers, positi...
2023-06-30 11:57:31 ET Abcam ( NASDAQ: ABCM ) ADRs rose 4% on a report that the biotechnology supplier is seeing initial interest from Danaher ( DHR ) and Agilent Technologies ( A ). Abcam ( ABCM ) has also separately reached out to other companies, including G...
2023-06-29 07:30:00 ET Summary GE HealthCare Technologies, a spin-off from General Electric, is performing well with a market cap of around $35 billion and strong tailwinds in the healthcare industry. The company operates in four business segments: Imaging, Ultrasound, Patient Car...
2023-06-26 11:00:28 ET Summary The bioprocessing market is currently in a downturn and pulling companies like Danaher and Sartorius down. Danaher has a clean balance sheet to make good deals in this downturn. Margins have temporary headwinds but should recover in 2024. At ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...